Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
43,119,761
-
Share change
-
-1,311,448
-
Total reported value
-
$9,315,950,531
-
Put/Call ratio
-
46%
-
Price per share
-
$216.08
-
Number of holders
-
409
-
Value change
-
-$262,053,365
-
Number of buys
-
173
-
Number of sells
-
214
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2021
As of 31 Dec 2021 UNITED THERAPEUTICS Corp - Common Stock (UTHR) had 409 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 43,119,761 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, STATE STREET CORP, Bank of New York Mellon Corp, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, and FULLER & THALER ASSET MANAGEMENT, INC..
This table shows 409 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.